Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Urology
|
October 7, 2014
Reply: To PMID 25283701
Jonathan L Silberstein, Oliver A Sartor
The Lancet. Oncology
|
January 5, 2017
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA
Charles L Bennett, Oliver A Sartor, James O Armitage, et al.
The Lancet. Oncology
|
March 11, 2015
Japanese regulatory authority's perspective on biosimilars - authors' reply
Charles L Bennett, Brian Chen, Terhi Hermanson, et al.
Case Reports in Hematology
|
February 25, 2020
A Case Report with Severe Thrombocytopenia Induced by Axitinib
Ulkuhan I Koksal, Janeiro Goffin, Brian Lewis, et al.
Carcinogenesis
|
January 5, 2008
Interactions of cytokine gene polymorphisms in prostate cancer risk
Jovanny Zabaleta, Hui-Yi Lin, Rosa A Sierra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts
Jack R Andrews, Yohan Kim, Edlira Horjeti, et al.
The Oncologist
|
February 15, 2021
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
Charles L Bennett, Sumimasa Nagai, Andrew C Bennett, et al.
European Urology
|
July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics
Stefano Fanti, Fabio Turco, Bertrand Tombal, et al.
European Urology
|
December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
European Urology
|
October 11, 2024
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Silke Gillessen, Fabio Turco, Ian D Davis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Urology
|
October 7, 2014
Reply: To PMID 25283701
Jonathan L Silberstein, Oliver A Sartor
The Lancet. Oncology
|
January 5, 2017
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA
Charles L Bennett, Oliver A Sartor, James O Armitage, et al.
The Lancet. Oncology
|
March 11, 2015
Japanese regulatory authority's perspective on biosimilars - authors' reply
Charles L Bennett, Brian Chen, Terhi Hermanson, et al.
Case Reports in Hematology
|
February 25, 2020
A Case Report with Severe Thrombocytopenia Induced by Axitinib
Ulkuhan I Koksal, Janeiro Goffin, Brian Lewis, et al.
Carcinogenesis
|
January 5, 2008
Interactions of cytokine gene polymorphisms in prostate cancer risk
Jovanny Zabaleta, Hui-Yi Lin, Rosa A Sierra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts
Jack R Andrews, Yohan Kim, Edlira Horjeti, et al.
The Oncologist
|
February 15, 2021
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
Charles L Bennett, Sumimasa Nagai, Andrew C Bennett, et al.
European Urology
|
July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics
Stefano Fanti, Fabio Turco, Bertrand Tombal, et al.
European Urology
|
December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
European Urology
|
October 11, 2024
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Silke Gillessen, Fabio Turco, Ian D Davis, et al.
Page
of 1